Advocacy intelligence hub — real-time data for patient organizations
Milton S. Hershey Medical Center — NA
Massachusetts General Hospital — PHASE4
The University of Texas Health Science Center, Houston — NA
Dartmouth-Hitchcock Medical Center — NA
University of Pittsburgh — NA
University of California, Davis — NA
New York State Institute for Basic Research — NA
University of South Carolina — NA
Karuna Therapeutics, Inc., a Bristol Myers Squibb company — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
DEXMEDETOMIDINE HYDROCHLORIDE
(DEXMEDETOMIDINE HYDROCHLORIDE)standardSun Pharmaceuticals Industries, Inc.
12.1 Mechanism of Action Dexmedetomidine Injection is a relatively selective centrally acting alpha 2 -adrenergic agonist with sedative properties. Al...
Yan Li, PhD
Oregon Health and Science University
Alexander Kolevzon, MD, MD
Icahn School of Medicine at Mount Sinai
📍 NEW YORK, NY
Forbes D Porter, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
📍 Bethesda, Maryland
Joanne Kurtzberg, MD, M.D
Duke University
📍 DURHAM, NC
Logan K Wink, MD, M.D
Children's Hospital Medical Center, Cincinnati
📍 CINCINNATI, OH
Eric Hollander, MD
Montefiore Medical Center